Elevated SARS-CoV-2-Specific Antibody Levels in Patients with Post-COVID Syndrome
With the routine use of effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines, the number of life-threatening coronavirus disease 2019 (COVID-19) courses have largely been reduced. However, multiple COVID-19 convalescents, even after asymptomatic to moderate disease, suffer...
Сохранить в:
| Главные авторы: | , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI AG
2023-03-01
|
| Серии: | Viruses |
| Предметы: | |
| Online-ссылка: | https://www.mdpi.com/1999-4915/15/3/701 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|